Testing superiority and non-inferiority hypotheses in active controlled clinical trials

被引:19
作者
Tsong, Y [1 ]
Zhang, J [1 ]
机构
[1] US FDA, CDER, OPaSS, Off Biostat, Rockville, MD 20857 USA
关键词
superiority test; non-inferiority test; switching; simultaneous test; STATISTICAL-METHODS; PLACEBO; EQUIVALENCE;
D O I
10.1002/bimj.200410089
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Switching between testing for superiority and non-inferiority has been an important statistical issue in the design and analysis of active controlled clinical trial. In practice, it is often conducted with a two-stage testing procedure. It has been assumed that there is no type I error rate adjustment required when either switching to test for non-inferiority once the data fail to support the superiority claim or switching to test for superiority once the null hypothesis of non-inferiority is rejected with a pre-specified non-inferiority margin in a generalized historical control approach. However, when using a cross-trial comparison approach for non-inferiority testing, controlling the type I error rate sometimes becomes an issue with the conventional two-stage procedure. We propose to adopt a single-stage simultaneous testing concept as proposed by Ng (2003) to test both non-inferiority and superiority hypotheses simultaneously. The proposed procedure is based on Fieller's confidence interval procedure as proposed by Hauschke et al. (1999).
引用
收藏
页码:62 / 74
页数:13
相关论文
共 20 条
[1]   SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J].
DUNNETT, CW ;
GENT, M .
BIOMETRICS, 1977, 33 (04) :593-602
[2]   The use of putative placebo in active control trials: two applications in a regulatory setting [J].
Durrleman, S ;
Chaikin, P .
STATISTICS IN MEDICINE, 2003, 22 (06) :941-952
[3]  
Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212
[4]  
Hauschke D, 1999, STAT MED, V18, P93, DOI 10.1002/(SICI)1097-0258(19990115)18:1<93::AID-SIM992>3.3.CO
[5]  
2-#
[6]  
Holmgren E B, 1999, J Biopharm Stat, V9, P651, DOI 10.1081/BIP-100101201
[7]  
Hung H M James, 2004, J Biopharm Stat, V14, P327
[8]   Some fundamental issues with non-inferiority testing in active controlled trials [J].
Hung, HMJ ;
Wang, SJ ;
Tsong, YL ;
Lawrence, J ;
O'Neil, RT .
STATISTICS IN MEDICINE, 2003, 22 (02) :213-225
[9]  
Morikawa T, 1995, J Biopharm Stat, V5, P297, DOI 10.1080/10543409508835115
[10]  
Ng Tie-Hua, 2003, J Biopharm Stat, V13, P629, DOI 10.1081/BIP-120024199